Servier voluntary admission: rep sent unsolicited promotional email and created promotional letters (AUTH/1889/9/06)

📅 2006 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/1889/9/06
CompanyServier Laboratories Ltd
TypeVoluntary admission treated as a complaint
IssueUnsolicited promotional email; rep-created promotional letters without certification/prescribing information; inadequate instructions/training evidence
ProductProtelos (strontium ranelate)
Applicable Code year2006
Complaint received / proceedings commenced13 September 2006
Completed02 November 2006
AppealNo appeal
Breach clauses9.1, 9.9, 15.2 and 15.9
SanctionsUndertaking received; additional sanctions not stated
Related follow-onPanel raised training-material concerns as separate complaint: AUTH/1906/10/06

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • In responding to a separate case (AUTH/1884/8/06), Servier disclosed additional issues: a representative’s inappropriate use of email and creation/use of letters.
  • The PMCPA Director treated this voluntary admission as a complaint because it involved potentially serious issues (promotional email without prior permission; rep-created promotional material).
  • A representative emailed a hospital doctor inviting her to speak at a meeting and suggested a lunchtime meeting to discuss Protelos (strontium ranelate) and data on non-vertebral fractures in the over 80s.
  • The representative also sent a letter to the same doctor to rebook a cancelled appointment to discuss “new evidence behind Protelos…”, ending with an emboldened question: “Would you recommend for patients unable to take the Bisphosphonates, that Protelos is the next option in line with the formulary?”
  • Servier stated these actions were contrary to company instructions; the representative was disciplined.
  • The Panel reviewed training/instructions and noted the company had not established the representative had received relevant training when the initial email was sent; training materials were undated and did not clearly address unsolicited promotional email or rep-created promotional letters.
⚖️

Outcome

  • The Panel ruled the email and letter were promotional.
  • Breach found for sending a promotional email without prior permission from the recipient.
  • Breach found for failure to maintain high standards and for inadequate company instructions/training controls around email use and creation of promotional material.
  • No breach of Clause 2 was ruled (Panel said Clause 2 is reserved for particular censure and the circumstances did not warrant it).
  • The Panel was extremely concerned about training materials and decided to raise this as a separate complaint (Case AUTH/1906/10/06).
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training